O95319 (CELF2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 98.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: CUGBP Elav-like family member 2 Short name=CELF-2 Alternative name(s): Bruno-like protein 3 CUG triplet repeat RNA-binding protein 2 Short name=CUG-BP2 CUG-BP- and ETR-3-like factor 2 ELAV-type RNA-binding protein 3 Short name=ETR-3 Neuroblastoma apoptosis-related RNA-binding protein Short name=hNAPOR RNA-binding protein BRUNOL-3 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 508 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | RNA-binding protein implicated in the regulation of several post-transcriptional events. Involved in pre-mRNA alternative splicing, mRNA translation and stability. Mediates exon inclusion and/or exclusion in pre-mRNA that are subject to tissue-specific and developmentally regulated alternative splicing. Specifically activates exon 5 inclusion of TNNT2 in embryonic, but not adult, skeletal muscle. Activates TNNT2 exon 5 inclusion by antagonizing the repressive effect of PTB. Acts as both an activator and repressor of a pair of coregulated exons: promotes inclusion of the smooth muscle (SM) exon but exclusion of the non-muscle (NM) exon in actinin pre-mRNAs. Promotes inclusion of exonS 21 and exclusion of exon 5 of the NMDA receptor R1 pre-mRNA. Involved in the apoB RNA editing activity. Increases COX2 mRNA stability and inhibits COX2 mRNA translation in epithelial cells after radiation injury By similarity. Modulates the cellular apoptosis program by regulating COX2-mediated prostaglandin E2 (PGE2) expression By similarity. Binds to (CUG)n triplet repeats in the 3'-UTR of transcripts such as DMPK. Binds to the muscle-specific splicing enhancer (MSE) intronic sites flanking the TNNT2 alternative exon 5. Binds preferentially to UG-rich sequences, in particular UG repeat and UGUU motifs. Binds to apoB mRNA, specifically to AU-rich sequences located immediatly upstream of the edited cytidine. Binds AU-rich sequences in the 3'-UTR of COX2 mRNA By similarity. Binds to an intronic RNA element responsible for the silencing of exon 21 splicing By similarity. Binds to (CUG)n repeats By similarity. Ref.11 Ref.12 Ref.13 Ref.14 Ref.15 Ref.16 Ref.17 |
| Subunit structure | Interacts with A1CF By similarity. |
| Subcellular location | Nucleus. Cytoplasm. Note: Accumulates in the cytoplasm after ionizing radiation By similarity. Colocalizes with APOBEC1 and A1CF. RNA-binding activity is detected in both nuclear and cytoplasmic compartments. Ref.10 Ref.11 Ref.15 |
| Tissue specificity | Expressed in frontal cortex. Isoform 1 is expressed in brain and lung. Isoform 2 is expressed in heart, brain, placenta, lung, liver, kidney, skeletal muscle and pancreas. Isoform 4 is expressed in heart, lung, skeletal muscle, kidney and pancreas. Ref.2 Ref.3 Ref.4 Ref.12 Ref.18 |
| Developmental stage | Isoform 1 is expressed in fetal brain. Isoform 2 is expressed in fetal heart, brain, thymus, lung, liver, skeletal muscle, kidney and spleen. Isoform 4 is expressed in fetal heart, brain, thymus, lung and skeletal muscle. Ref.2 Ref.4 |
| Sequence similarities | Belongs to the CELF/BRUNOL family. Contains 3 RRM (RNA recognition motif) domains. |
Ontologies
| Keywords | |
|---|---|
| Biological process | mRNA processing |
| Cellular component | Cytoplasm Nucleus |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Repeat |
| Ligand | RNA-binding |
| Molecular function | Repressor |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | RNA processing Traceable author statement PubMed 9887331. Source: ProtInc mRNA processingInferred from electronic annotation. Source: UniProtKB-KW regulation of heart contractionTraceable author statement PubMed 9887331. Source: ProtInc |
| Cellular_component | cytoplasm Inferred from electronic annotation. Source: UniProtKB-SubCell nucleusInferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular_function | RNA binding Traceable author statement PubMed 9887331. Source: ProtInc nucleotide bindingInferred from electronic annotation. Source: InterPro |
| Complete GO annotation... | |
Alternative products
| This entry describes 5 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: O95319-1) Also known as: NAPOR-3; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: O95319-2) Also known as: NAPOR-1; The sequence of this isoform differs from the canonical sequence as follows: 1-24: Missing. 358-358: A → AVAQMLS | ||||||
| Isoform 3 (identifier: O95319-3) The sequence of this isoform differs from the canonical sequence as follows: 1-18: MRCPKSAVTMRNEELLLS → MMVEGRLLVPDRI 358-358: A → AGTINTPRSKRLLLPKDNN | ||||||
| Isoform 4 (identifier: O95319-4) Also known as: NAPOR-2; The sequence of this isoform differs from the canonical sequence as follows: 1-18: MRCPKSAVTMRNEELLLS → MMVEGRLLVPDRI 358-358: A → AVAQMLS | ||||||
| Isoform 5 (identifier: O95319-5) The sequence of this isoform differs from the canonical sequence as follows: 1-24: Missing. 359-359: G → GTINS |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 508 | 508 | CUGBP Elav-like family member 2 | PRO_0000295189 | |||||
Regions | |||||||||
| Domain | 40 – 123 | 84 | RRM 1 | ||||||
| Domain | 132 – 212 | 81 | RRM 2 | ||||||
| Domain | 423 – 501 | 79 | RRM 3 | ||||||
| Region | 1 – 283 | 283 | Necessary for RNA-binding, TNNT2 exon 5 and NMDA R1 exon 21 inclusion | ||||||
| Region | 357 – 508 | 152 | Necessary for RNA-binding, TNNT2 exon 5 and NMDA R1 exon 21 inclusion | ||||||
| Compositional bias | 284 – 397 | 114 | Ala-rich | ||||||
Natural variations | |||||||||
| Alternative sequence | 1 – 24 | 24 | Missing in isoform 2 and isoform 5. | VSP_026796 | |||||
| Alternative sequence | 1 – 18 | 18 | MRCPK…ELLLS → MMVEGRLLVPDRI in isoform 3 and isoform 4. | VSP_026797 | |||||
| Alternative sequence | 358 | 1 | A → AVAQMLS in isoform 2 and isoform 4. | VSP_026798 | |||||
| Alternative sequence | 358 | 1 | A → AGTINTPRSKRLLLPKDNN in isoform 3. | VSP_026799 | |||||
| Alternative sequence | 359 | 1 | G → GTINS in isoform 5. | VSP_026800 | |||||
| Natural variant | 438 | 1 | D → H. Ref.1 Ref.3 Corresponds to variant rs1050942 [ dbSNP | Ensembl ]. | VAR_052202 | |||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Fluorescent differential display analysis of gene expression in apoptotic neuroblastoma cells." Choi D.-K., Ito T., Mitsui Y., Sakaki Y. Gene 223:21-31(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), VARIANT HIS-438. Tissue: Brain. |
| [2] | "Developmentally-regulated expression of mNapor encoding an apoptosis-induced ELAV-type RNA binding protein." Choi D.-K., Ito T., Tsukahara F., Hirai M., Sakaki Y. Gene 237:135-142(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), TISSUE SPECIFICITY, DEVELOPMENTAL STAGE. Tissue: Brain. |
| [3] | "A family of human RNA-binding proteins related to the Drosophila Bruno translational regulator." Good P.J., Chen Q., Warner S.J., Herring D.C. J. Biol. Chem. 275:28583-28592(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, VARIANT HIS-438. Tissue: Heart. |
| [4] | "Genomic organization and isoform-specific tissue expression of human NAPOR (CUGBP2) as a candidate gene for familial arrhythmogenic right ventricular dysplasia." Li D., Bachinski L.L., Roberts R. Genomics 74:396-401(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], TISSUE SPECIFICITY, DEVELOPMENTAL STAGE. |
| [5] | "Mutation screening of the NAPOR gene: a candidate for adult-onset primary open angle glaucoma (GLC1E) on 10p14." Sarfarazi M., Rezaie T. Submitted (OCT-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5). |
| [6] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5). Tissue: Synovium. |
| [7] | "The DNA sequence and comparative analysis of human chromosome 10." Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L., Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K., Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L., Taylor A., Battles J. Rogers J.Nature 429:375-381(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [8] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [9] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). Tissue: Brain. |
| [10] | "Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy." Timchenko L.T., Miller J.W., Timchenko N.A., DeVore D.R., Datar K.V., Lin L., Roberts R., Caskey C.T., Swanson M.S. Nucleic Acids Res. 24:4407-4414(1996) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, RNA-BINDING. |
| [11] | "Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor." Anant S., Henderson J.O., Mukhopadhyay D., Navaratnam N., Kennedy S., Min J., Davidson N.O. J. Biol. Chem. 276:47338-47351(2001) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, RNA-BINDING, SUBCELLULAR LOCATION. |
| [12] | "The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing." Ladd A.N., Charlet-B N., Cooper T.A. Mol. Cell. Biol. 21:1285-1296(2001) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, RNA-BINDING, TISSUE SPECIFICITY. |
| [13] | "Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing." Charlet-B N., Logan P., Singh G., Cooper T.A. Mol. Cell 9:649-658(2002) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, RNA-BINDING. |
| [14] | "Antagonistic regulation of alpha-actinin alternative splicing by CELF proteins and polypyrimidine tract binding protein." Gromak N., Matlin A.J., Cooper T.A., Smith C.W. RNA 9:443-456(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, RNA-BINDING. |
| [15] | "ETR-3 and CELF4 protein domains required for RNA binding and splicing activity in vivo." Singh G., Charlet-B N., Han J., Cooper T.A. Nucleic Acids Res. 32:1232-1241(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, RNA-BINDING. |
| [16] | "Identification of putative new splicing targets for ETR-3 using sequences identified by systematic evolution of ligands by exponential enrichment." Faustino N.A., Cooper T.A. Mol. Cell. Biol. 25:879-887(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, RNA-BINDING. |
| [17] | "Identification of CELF splicing activation and repression domains in vivo." Han J., Cooper T.A. Nucleic Acids Res. 33:2769-2780(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [18] | "ETR-3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I." Leroy O., Dhaenens C.-M., Schraen-Maschke S., Belarbi K., Delacourte A., Andreadis A., Sablonniere B., Buee L., Sergeant N., Caillet-Boudin M.-L. J. Neurosci. Res. 84:852-859(2006) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [19] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF090694 mRNA. Translation: AAD13761.1. AF090693 mRNA. Translation: AAD13760.1. AF036956 mRNA. Translation: AAD02074.1. U69546 mRNA. Translation: AAB09040.1. AF295068 AF295067 Genomic DNA. Translation: AAK72223.1.AF295068 AF314199 Genomic DNA. Translation: AAK72224.1.AF295068 AF295067 Genomic DNA. Translation: AAK92699.1.AF432906 mRNA. Translation: AAL27627.1. AK316354 mRNA. Translation: BAH14725.1. AL157704, AC026887, AL136320 Genomic DNA. Translation: CAH70230.1. AL136320, AC026887, AL157704 Genomic DNA. Translation: CAI20169.1. CH471072 Genomic DNA. Translation: EAW86346.1. BC036391 mRNA. Translation: AAH36391.1. |
| IPI | IPI00410277. IPI00607544. IPI00845479. IPI00845480. IPI00853320. |
| RefSeq | NP_001020247.1. NM_001025076.2. NP_001020248.1. NM_001025077.2. NP_001077060.1. NM_001083591.1. NP_006552.3. NM_006561.3. |
| UniGene | Hs.309288. |
3D structure databases | |
| HSSP | HSSP built from PDB template 2CPZ based on UniProtKB Q92879. |
| ProteinModelPortal | O95319. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | O95319. 4 interactions. |
| MINT | MINT-2868664. |
| STRING | 9606.ENSP00000389951. |
PTM databases | |
| PhosphoSite | O95319. |
2D gel databases | |
| UCD-2DPAGE | O95319. |
Proteomic databases | |
| PaxDb | O95319. |
| PRIDE | O95319. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000315874; ENSP00000315328; ENSG00000048740. ENST00000354440; ENSP00000346426; ENSG00000048740. ENST00000379261; ENSP00000368563; ENSG00000048740. ENST00000399850; ENSP00000382743; ENSG00000048740. ENST00000416382; ENSP00000406451; ENSG00000048740. ENST00000417956; ENSP00000404834; ENSG00000048740. ENST00000427450; ENSP00000388530; ENSG00000048740. |
| GeneID | 10659. |
| KEGG | hsa:10659. |
| UCSC | uc001iki.4. human. uc001ikk.2. human. uc001iko.4. human. uc001ikp.4. human. uc010qbj.1. human. |
Organism-specific databases | |
| CTD | 10659. |
| GeneCards | GC10P011049. |
| HGNC | HGNC:2550. CELF2. |
| HPA | CAB016395. HPA035813. |
| MIM | 602538. gene. |
| neXtProt | NX_O95319. |
| PharmGKB | PA27046. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG251494. |
| HOVERGEN | HBG107646. |
| KO | K13207. |
Gene expression databases | |
| ArrayExpress | O95319. |
| Bgee | O95319. |
| CleanEx | HS_CUGBP2. |
| Genevestigator | O95319. |
Family and domain databases | |
| Gene3D | 3.30.70.330. 3 hits. |
| InterPro | IPR002343. Hud_Sxl_RNA. IPR012677. Nucleotide-bd_a/b_plait. IPR000504. RRM_dom. [Graphical view] |
| Pfam | PF00076. RRM_1. 3 hits. [Graphical view] |
| PRINTS | PR00961. HUDSXLRNA. |
| SMART | SM00360. RRM. 3 hits. [Graphical view] |
| PROSITE | PS50102. RRM. 3 hits. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | CELF2. human. |
| GenomeRNAi | 10659. |
| NextBio | 40529. |
| SOURCE | Search... |
Entry information
| Entry name | CELF2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O95319 Secondary accession number(s): B7ZAN9 Q9UL67 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 10 Human chromosome 10: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
